(Washington, D.C. and New York) – Akin announced today that it has achieved a significant victory on behalf of Armistice Capital in the U.S. District Court for the Northern District of California, in the case In re: Vaxart, Inc. Securities Litigation.
On April 28, 2026, following a three-week trial, a California federal jury issued a verdict exonerating Akin’s clients Armistice and two of its executives on securities class action claims involving alleged securities fraud and insider trading. In...
Continue Reading
Sign up for FREE to read the full article and access 146K+ alternative investment headlines.